Rafferty Asset Management LLC increased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 375,148 shares of the biopharmaceutical company’s stock after purchasing an additional 16,626 shares during the […]
CIBC Asset Management Inc trimmed its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 443,459 shares of the biopharmaceutical company’s stock after selling 3,137 shares during the period. CIBC […]
Eagle Asset Management Inc. lifted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 23.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 317,539 shares of the biopharmaceutical company’s stock after purchasing an additional 60,697 shares during the period. Eagle Asset Management Inc.’s holdings in Gilead Sciences were worth […]
Chiron Capital Management LLC trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 17.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 13,280 shares of the biopharmaceutical company’s stock after selling 2,898 shares during the quarter. Gilead Sciences comprises about 0.9% […]
Bank of Nova Scotia grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 43.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 427,751 shares of the biopharmaceutical company’s stock after buying an additional 130,552 shares during the […]